Xenglu Met 5/850mg Tablet – for Type 2 Diabetes
Xenglu Met 5/850mg Tablet – for Type 2 Diabetes
Xenglu Met 5/850mg Tablet – for Type 2 Diabetes
Description
Xenglu Met 5/850mg Tablet – Effective Mid-Strength Combo with Proven Heart & Kidney Protection
Xenglu Met 5/850mg Tablet combines empagliflozin 5mg (SGLT2 inhibitor) with metformin extended-release 850mg in a single once-daily tablet. This well-balanced mid-strength formulation provides strong glucose lowering through two complementary pathways while remaining gentle on the stomach thanks to the extended-release metformin. Patients enjoy excellent A1C reduction, modest weight loss, lower blood pressure, and the full clinically proven cardiovascular and renal protective benefits of empagliflozin – all in one convenient pill.
